AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06423534 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Breastfeeding Health Educational Program
Description: Breastfeeding is a mother's priceless gift to her infant and nature's own method of nurturing a baby. Therefore, this study will be conducted to evaluate the primigravida mother's breastfeeding's knowledge, attitude and corrective technique through the implementation of an educational program and to ascertain the efficacy of such a program.
Study NCT06423534 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Breastfeeding Health Educational Program
Description: Breastfeeding is a mother's priceless gift to her infant and nature's own method of nurturing a baby. Therefore, this study will be conducted to evaluate the primigravida mother's breastfeeding's knowledge, attitude and corrective technique through the implementation of an educational program and to ascertain the efficacy of such a program.
Study NCT04993014 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pertuzumab
Description: Adjuvant trastuzumab + pertuzumab (arm B of the 2 cohorts: 1: HER2 positive CTCs at baseline and 2: HER2 negative/absent CTCs at baseline)
Study NCT04993014 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Trastuzumab
Description: Adjuvant trastuzumab (arm A of the 2 cohorts: 1: HER2 positive CTCs at baseline and 2: HER2 negative/absent CTCs at baseline) Association with pertuzumab in arm B of the 2 cohorts
Study NCT04993014 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trastuzumab
Description: Adjuvant trastuzumab (arm A of the 2 cohorts: 1: HER2 positive CTCs at baseline and 2: HER2 negative/absent CTCs at baseline) Association with pertuzumab in arm B of the 2 cohorts
Study NCT04993014 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Circulating tumor cells
Description: Blood sample collection for examination of CTCs at baseline of neoadjuvant therapy. Tests for HER2 positivity will be done.
Study NCT04993014 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Circulating tumor cells
Description: Blood sample collection for examination of CTCs at baseline of neoadjuvant therapy. Tests for HER2 positivity will be done.
Study NCT05247684 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: IV infusion
Study NCT05247684 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: IV infusion
Study NCT05247684 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: IV infusion
Study NCT05626179 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: [14C] IBI351
Description: The oral formulation of \[14C\] IBI351 was formulated as a suspension for subjects to take orally in drinking water under fasting conditions
Study NCT04763889 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CBT
Description: CBT for those with an allergy and anxiety
Study NCT04655924 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Clinical Decision Support System
Description: Clinical Decision Support System using Measurement-Based Care and Digital Decision Support Platform
Study NCT04994665 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: sleeve gastrectomy
Description: The sleeve gastrectomy is a surgical weight-loss procedure, about 80% of the stomach is removed
Study NCT04994665 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: sleeve gastrectomy with omentopexy
Description: After sleeve gastrectomy procedure, the omentopexy involves suturing the omentum back to the greater curvature of the stomach in several locations, depending on the length of the greater curvature
Study NCT06291467 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Blood samples
Description: Blood samples will be collected at both visit between 8:30 a.m. and 9:30 a.m. and fasting from midnight.
Study NCT06291467 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Blood samples
Description: Blood samples will be collected at both visit between 8:30 a.m. and 9:30 a.m. and fasting from midnight.
Study NCT06291467 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: questionnaires
Description: Questionnaires will be administrated at both visits to assess the suicide spectrum, the depression level and some personality traits.~Hetero-questionnaires will be administrated during a clinical interview conducted by a psychiatrist or psychologist at the inclusion.~* MINI 7.0 Mini-International Neuropsychiatric Interview :~* MADRS (Montgomery Asberg Depression Scale)~* C-SSRS (Columbia-Suicide Severity Rating Scale)~* FAST (Functioning Assessment Short Test)~Self-administered questionnaire will be completed by the participant at the inclusion and at the end of hospitalisation (D7+/- 2 days) :~* STAI-Y (State-Trait Anxiety Inventory )~* PPP-VAS (Visual Analog Scale to measure Psychological and Physical Pain)~* SHAPS (Snaith-Hamilton-Pleasure Scale )~* CTQ (Childhood Trauma Questionnaire)~* ESUL : Echelle de solitude de l'université de Laval~* BIS-11 : (Barratt Impulsiveness Scale)~* QIDS (Quick Inventory of Depressive Symptomatology)
Study NCT06291467 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: questionnaires
Description: Questionnaires will be administrated at both visits to assess the suicide spectrum, the depression level and some personality traits.~Hetero-questionnaires will be administrated during a clinical interview conducted by a psychiatrist or psychologist at the inclusion.~* MINI 7.0 Mini-International Neuropsychiatric Interview :~* MADRS (Montgomery Asberg Depression Scale)~* C-SSRS (Columbia-Suicide Severity Rating Scale)~* FAST (Functioning Assessment Short Test)~Self-administered questionnaire will be completed by the participant at the inclusion and at the end of hospitalisation (D7+/- 2 days) :~* STAI-Y (State-Trait Anxiety Inventory )~* PPP-VAS (Visual Analog Scale to measure Psychological and Physical Pain)~* SHAPS (Snaith-Hamilton-Pleasure Scale )~* CTQ (Childhood Trauma Questionnaire)~* ESUL : Echelle de solitude de l'université de Laval~* BIS-11 : (Barratt Impulsiveness Scale)~* QIDS (Quick Inventory of Depressive Symptomatology)
Study NCT06270563 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Postural advice
Description: The patients received advice about maintaining good posture when sitting, standing, reading, driving, or lifting; taking breaks; sleeping on back or side with a pillow supporting head/neck; avoiding prolonged phone use; adjusting car seat; reading stand for upright posture; keeping objects close when lifting; and using pillows for support when breastfeeding.
Study NCT06270563 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Postural advice
Description: The patients received advice about maintaining good posture when sitting, standing, reading, driving, or lifting; taking breaks; sleeping on back or side with a pillow supporting head/neck; avoiding prolonged phone use; adjusting car seat; reading stand for upright posture; keeping objects close when lifting; and using pillows for support when breastfeeding.
Study NCT06270563 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional exercise treatment
Description: The exercise program included strengthening of deep flexor muscles and shoulder retractors while stretching of cervical extensors and pectoral muscles.
Study NCT06270563 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional exercise treatment
Description: The exercise program included strengthening of deep flexor muscles and shoulder retractors while stretching of cervical extensors and pectoral muscles.
Study NCT06270563 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Scapular stabilization exercises
Description: Scapular Stabilization exercise was composed of four exercise programs, including scapula retraction exercise, scapula mobilization exercise, and scapula dynamic stabilization exercise I and II.
Study NCT06270563 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High intensity Laser therapy
Description: There were two phases in every session, the wavelength is 1064 nm, size of spacer is 60 mm in both phases:~Phase I (analgesic phase): the application was made by moving the applicator perpendicular to the skin in continuous circular movements at trigger points detected by acupuncture, power was 8.00 w with a dosage of 5 J/cm2, surface area 50 cm2, frequency 25 HZ, treatment time in this phase was 3 minutes and total energy received at this phase was 250 J.~Phase II (bio stimulation): the application was made at the pain inflicting region by using continuous linear movements and prevent static application, The power was 8.00 w with a continuous frequency, dosage of 50 J/cm2, surface area 50 cm2, treatment time in this phase was 5 minutes and the total energy that was delivered to the patient during this phase was 2500 J.
Study NCT05875389 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual assessment
Description: virtual assessment with a stroke neurologist/advanced practice nurse, with interdisciplinary support, to facilitate the care of patients admitted to primary stroke centres using existing tools for remote evaluation and review.
Study NCT05055609 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TRE-515
Description: TRE-515 will be administered orally once daily at least 1 hour prior or 2 hours after eating at approximately the same time each day. Dosing will be continuous with no breaks between cycles. Subjects will continue to receive successive cycles of TRE-515 treatment as long as they do not demonstrate progressive disease, experience an unacceptable toxicity, and both the Sponsor and PI consider additional treatment with TRE-515 to be within the best interest of the subject.
Study NCT05402722 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Eribulin
Description: Eribulin Mesylate，1.4mg/m2，Intravenous infusion，d1，d8，3-week cycle
Study NCT05402722 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: anti-PD-1 antibody
Description: Sintilimab Injection，Intravenous infusion，200mg，3-week cycle
Study NCT05874583 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Combined route administration of Tranexamic acid
Description: tranexamic acid in topical route administration
Study NCT05874583 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous route Tranexamic acid injection
Description: Intra venous route administration
Study NCT05528835 — intervention group
Intervention type: PROCEDURE
Intervention: Frozen embryo transfer
Description: All women in both groups will receive oral estradiol valerate 8 mg/ day from the second day of the menstrual cycle. Endometrial thickness will be assessed by vaginal ultrasonography at the tenth day of treatment. When endometrial thickness reached ≥ 7 mm all subjects, in addition to estrogen, they will receive progesterone vaginal suppositories 400 mg twice daily and 100 mg of progesterone intramuscularly daily. Frozen thawed embryo transfer will be at day 6 of progesterone. Estrogen and progesterone will be continued until 9-10 weeks of gestation
Study NCT04868305 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Intramedullary nail
Description: Intertan nail (Smith \& Nephew)\* or Gamma 3 nail (Stryker)\*~\* All of the above-mentioned products are subjects to change into an equivalent product
Study NCT04868305 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Hip arthroplasty
Description: Total hip arthroplasty:~* Cemented: Lubinus (Link)\*, Exeter (Stryker)\*~* Uncemented: Restoration Modular (Stryker)\*~* Cup: Cemented Avantage dual mobility cup (Zimmer Biomet)\*~Hemiarthroplasty:~* Cemented: Lubinus (Link)\*, Exeter (Stryker)\*~* Uncemented: Restoration Modular (Stryker)\*~  * All of the above-mentioned products are subjects to change into an equivalent product
Study NCT04784026 — intervention group
Intervention type: OTHER
Intervention: Gait assessment (single)
Description: The single walk will be evaluated with a 10-meter walking test and a G-Walk portable device.
Study NCT04784026 — intervention group
Intervention type: OTHER
Intervention: Dual task gait assessment (motor+motor)
Description: The dual task gait, 10-meter walking test and a motor (carrying a full water glass) will be combined with the task and evaluated with the G-Walk portable device.
Study NCT04784026 — intervention group
Intervention type: OTHER
Intervention: Dual tak gait assessment (motor+cognitive)
Description: The dual task gait will be combined with a 10-meter walking test and a cognitive (1-back test) task and evaluated with the G-Walk portable device.
Study NCT04766034 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Simulated Grocery Shopping Exercise
Description: Participants will click a link and simulate a shopping experience by selecting a week's worth of Supplemental Nutrition Assistance Program (SNAP)-eligible groceries for their household in a web-based supermarket platform
Study NCT04766034 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Simulated Grocery Shopping Exercise
Description: Participants will click a link and simulate a shopping experience by selecting a week's worth of Supplemental Nutrition Assistance Program (SNAP)-eligible groceries for their household in a web-based supermarket platform
Study NCT05289154 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: self- applied acupressure plus Qigong course plus advice literature
Description: daily self applied acupressure over 20min plus 2 times per week online live Qigong course of each 45min- both over 8 weeks.
Study NCT05289154 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: advice literature with naturopathy
Description: advice literature with naturopathic remedies will be handed out and application will be supported with dairies and phone calls
Study NCT05502692 — intervention group
Intervention type: BEHAVIORAL
Intervention: CHARACTERISE
Description: Cohort 1 Cohort 2
Study NCT05525793 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transitional care model
Description: The patients who were assigned to this group with the transitional care model, 6 weeks of counseling and intervention training provided continuity of care and a safe transition, and patients were encouraged about symptom management and a healthy lifestyle.
Study NCT05255874 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aromatherapy
Description: Patients in the study group will rest for 5 minutes before and after the urodynamics procedure. All patients will be asked to fill in the 'Spielberger State Anxiety Scale' before and after the urodynamic procedure. Before and after the procedure, blood pressure, heart rate, respiratory rate, peripheral oxygen saturation will be measured. Blood will be drawn for serum cortisol level. In addition to the routine treatment and care practices of the unit, aromatherapy will be applied to the patients included in the study group. Aromatherapy application will be applied to all patients by the same researcher. Aromatherapy application will be started 5 minutes before the urodynamic procedure after the patient is taken to the urodynamic room, and lavender essential oil (3 drops in 300 cc water for 5 cubic meters of room) will be used with a diffuser until the end of the procedure.
Study NCT05850988 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: %80 Oxygen concentration
Description: Patients will be administered %80 Oxygen for 3 minutes during preoxygenation.
Study NCT05850988 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: %100 Oxygen concentration
Description: Patients will be administered %100 Oxygen for 3 minutes during preoxygenation.
Study NCT05286723 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multicomponent Training
Description: Warm up, aerobic training, stenght training, balance and coordination training and return to calm
Study NCT05691686 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Finely milled whole wheat-legume bread
Description: The intervention examines the effect of finely milled wheat-legume bread in subjects with normal body weight.
Study NCT05691686 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Less processed whole wheat-legume bread
Description: The intervention examines the effect of less processed whole wheat-legume bread in subjects with normal body weight.
Study NCT05691686 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Less processed whole wheat bread
Description: The intervention examines the effect of less processed whole wheat bread in subjects with normal body weight.
Study NCT05691686 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: White wheat bread
Description: The intervention examines the reference food product in subjects with normal body weight.
Study NCT06420544 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: JAPI: Cognitive, Emotional and Social Stimulation for Preschool Children
Description: Those children in the intervention group will play with the gaming platform Japi using a tablet device in a designated time given from schools' authorities. Early Year Educators will be present to help with the discipline and motivation of the students and Research Assistants will be there as well to provide technical support for the use of the equipment.~The intervention has 24 sessions, and the dosage will be two sessions of 15 minutes each per week for 12 weeks. Sessions number 1 to number 8 are focused on emotional regulation and inhibitory control. Sessions number 9 to 16 work on working memory and problem-solving. Sessions number 17 to 24 promote empathy and planification skills. Each session will have eight activities with increasing levels of difficulty.
Study NCT05291039 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Infliximab
Description: group 1 (n=20): patients will receive IFX
Study NCT05291039 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Adalimumab
Description: group 2 (n=20): patients will receive ADA
Study NCT06413368 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Maralixibat 9.5 MG/ML [Livmarli]
Description: Within Study subjects receiving 2 weeks of treatment with Maralixibat 9.5 MG/ML \[Livmarli\] and compare to baseline treatment.
Study NCT05837455 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: VENTANA MIB-1 Ki67 assay
Description: Ki67 scoring determination (standard of care) utilizing the Ki67 MIB-1 assay (clone 30-9) (VENTANA) will be performed at baseline, Week 4 (+/- 14 days - high-risk group only), and at time of surgery in accordance with the International Ki67 in Breast Cancer Working Group guidelines.
Study NCT05837455 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Oncotype DX® Recurrence Score
Description: Oncotype DX® Recurrence Score (RS) testing - assessing expression of 21 genes including 16 cancer-related genes and 5 reference genes - will be performed as standard of care in a central laboratory (Exact Sciences) on RNA extracted from formalin-fixed paraffin-embedded core-biopsy samples.
Study NCT05837455 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PAM50-based Prosigna breast cancer gene signature assay
Description: This PAM50-based Prosigna breast cancer gene signature assay for intrinsic molecular subtype determination will be performed on formalin-fixed, paraffin-embedded (FFPE) core-biopsy samples.
Study NCT05837455 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anastrozole
Description: Standard of care
Study NCT04688931 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: UGN-102
Description: UGN-102 consists of mitomycin and sterile hydrogel (a proprietary thermally responsive gel) that is used to reconstitute mitomycin before instillation. The reverse thermal properties of UGN-102 allow for local administration of mitomycin as a liquid under chilled conditions, with subsequent conversion to a semi-solid gel depot following instillation into the bladder.
Study NCT04688931 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: TURBT
Description: The current standard of care for treatment of LG-IR-NMIBC is TURBT under general anesthesia.
Study NCT04688931 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: TURBT
Description: The current standard of care for treatment of LG-IR-NMIBC is TURBT under general anesthesia.
Study NCT05837455 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Combination anthracycline and/or taxane based treatment
Description: Standard of care
Study NCT06084962 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: DeepTag-GPRC5D Targeted CAR T-cells
Description: Each subject receive DeepTag-GPRC5DTargeted CAR T-cells by intravenous infusion
Study NCT04513314 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Valproate
Description: Valproate sodium (enteral or intravenous) will be administered at a dosage of 10 to 15 mg/kg/day. The dosage may be increased by 5 to 10 mg/kg/week to achieve optimal clinical response. Ordinarily, optimal clinical response is achieved at daily doses below 60 mg/kg/day.
Study NCT04513314 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Quetiapine
Description: Enteral quetiapine dosing on Day 3: 25 mg to 50 mg twice daily. Increase in increments of 50 mg/day to 100 mg/day divided two on Days 4 and 5 to range of 50-400 mg/day by Day 7. Further adjustments can be made in increments of 25-50 mg twice a day, in intervals of not less than 2 days. Recommended dose range is 150-750 mg/day.
Study NCT04513314 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Standard of Care is a combination of IV dexmedetomidine (D), midazolam (M), ketamine (K) and propofol (P), at the discretion of treating physician.
Study NCT05730946 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Interview- based questionnaire
Description: Interview-based questionnaire by the use of an interview guide to explore and understand the Challenges faced in the past and the concerns for the future experienced by parents of CLP patients.